Pfizer Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Pfizer Inc trades at $28.18 (market cap $158.56B), while Direxion Daily Semiconductor Bear 3X Shares trades at $34.44 (market cap $1.96B). The key difference: Pfizer Inc is far larger — about 80.9× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Pfizer Inc pays a 6.18% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| PFE | SOXS | |
|---|---|---|
Market Cap | $158.56B | $1.96B |
Volume | 44,138,282 | 113,512,541 |
Sector | Health | Leveraged / Inverse |
52-Week High | $29.02 | $988.00 |
52-Week Low | $23.67 | $29.62 |
Typical Hold Time | 158 Days | 11 Days |
Enterprise Value | $210.06B | — |
Dividend Yield | 6.18% | — |
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $34.53, up 12.68% with a bearish technical signal. The fund provides inverse leveraged exposure to semiconductor stocks, making it highly volatile and suitable for short-term tactical trades rather than long-term investment. Recent performance reflects semiconductor sector weakness, with technical indicators showing mixed signals but overall bearish momentum.
The outlook remains challenging as SOXS faces structural headwinds from persistent AI hardware demand and semiconductor industry strength. Investment opportunities exist for tactical bearish bets during sector pullbacks, but risks include high volatility, decay from daily rebalancing, and potential for rapid losses if semiconductor stocks rebound. The fund is best suited for experienced traders with short-term horizons.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →